Search Results - "Girgis, Mark D"

Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer by Court, Colin M., Ankeny, Jacob S., Sho, Shonan, Winograd, Paul, Hou, Shuang, Song, Min, Wainberg, Zev A., Girgis, Mark D., Graeber, Thomas G., Agopian, Vatche G., Tseng, Hsian-Rong, Tomlinson, James S.

“…Background Occult metastatic tumors, below imaging thresholds, are a limitation of staging systems that rely on cross-sectional imaging alone and are a cause…”
Get full text

Impact of resection margin status on survival in pancreatic cancer patients after neoadjuvant treatment and pancreatoduodenectomy by Maeda, Shimpei, Moore, Alexandra M., Yohanathan, Lavanya, Hata, Tatsuo, Truty, Mark J., Smoot, Rory L., Cleary, Sean P., Nagorney, David M., Grotz, Travis E., Park, Eugene J., Girgis, Mark D., Reber, Howard A., Motoi, Fuyuhiko, Masuda, Toshiro, Unno, Michiaki, Kendrick, Michael L., Donahue, Timothy R.

“…Resection margin status has been recognized as an independent prognostic factor on overall survival in pancreatic cancer patients undergoing surgical…”
Get full text

Robotic approach mitigates perioperative morbidity in obese patients following pancreaticoduodenectomy by Girgis, Mark D, Zenati, Mazen S, Steve, Jennifer, Bartlett, David L, Zureikat, Amer, Zeh, Herbert J, Hogg, Melissa E

“…Abstract Introduction The aim was to evaluate the impact of obesity on perioperative outcomes in patients undergoing robotic pancreaticoduodenectomy (RPD)…”
Get full text

Acute Pancreatitis: A Review by Mederos, Michael A, Reber, Howard A, Girgis, Mark D

“…IMPORTANCE: In the United States, acute pancreatitis is one of the leading causes of hospital admission from gastrointestinal diseases, with approximately…”
Get full text

Dual antiplatelet management in the perioperative period: updated and expanded systematic review by Premji, Alykhan M, Blegen, Mariah B, Corley, Alyssa M, Ulloa, Jesus, Booth, Marika S, Begashaw, Meron, Larkin, Jody, Shekelle, Paul, Girgis, Mark D, Maggard-Gibbons, Melinda

“…Antiplatelet agents are central in the management of vascular disease. The use of dual antiplatelet therapy (DAPT) for the management of thromboembolic…”
Get full text

A Comprehensive Assessment of Accurate Lymph Node Staging and Preoperative Detection in Resected Pancreatic Cancer by Masuda, Toshiro, Dann, Amanda M., Elliott, Irmina A., Baba, Hideo, Kim, Stephen, Sedarat, Alireza, Muthusamy, V. Raman, Girgis, Mark D., Joe Hines, O., Reber, Howard A., Donahue, Timothy R.

“…Background The current (seventh edition) American Joint Commission on Cancer (AJCC) Staging System for pancreatic ductal adenocarcinoma (PDAC) dichotomizes…”
Get full text

Intraoperative and postoperative outcomes of robot-assisted cholecystectomy: a systematic review by Shenoy, Rivfka, Mederos, Michael A, Ye, Linda, Mak, Selene S, Begashaw, Meron M, Booth, Marika S, Shekelle, Paul G, Wilson, Mark, Gunnar, William, Maggard-Gibbons, Melinda, Girgis, Mark D

“…Rapid adoption of robotic-assisted general surgery procedures, particularly for cholecystectomy, continues while questions remain about its benefits and…”
Get full text

Anti-CA19-9 Diabody as a PET Imaging Probe for Pancreas Cancer by Girgis, Mark D., M.D, Kenanova, Vania, Ph.D, Olafsen, Tove, Ph.D, McCabe, Katelyn E., Ph.D, Wu, Anna M., Ph.D, Tomlinson, James S., M.D., Ph.D

“…Background Intact antibodies are poor imaging agents due to a long serum half-life (10–20 d) preventing adequate contrast between the tumor and surrounding…”
Get full text

An engineered anti-CA19-9 cys-diabody for positron emission tomography imaging of pancreatic cancer and targeting of polymerized liposomal nanoparticles by Girgis, Mark D., MD, Federman, Noah, MD, Rochefort, Matthew M., MD, McCabe, Katelyn E., PhD, Wu, Anna M., PhD, Nagy, Jon O., PhD, Denny, Christopher, MD, Tomlinson, James S., MD, PhD

“…Abstract Background Antibody-based therapeutics is a rapidly growing field. Small engineered antibody fragments demonstrate similar antigen affinity compared…”
Get full text

Low Grade Islet but Marked Exocrine Pancreas Inflammation in an Adult with Autoimmune Pre-Diabetes by Dry, Sarah M., Girgis, Mark D., Rosenberger, Madeline, Gurlo, Tatyana, Nomoto, Hiroshi, Butler, Peter C.

“…There is unexplained deficit in size and function of the exocrine pancreas in type 1 diabetes (T1D). We obtained pancreas from an individual with pre-T1D…”
Get full text

Circulating Tumor Cells: Metastases Caught in the Act by Zheng, Serena, Girgis, Mark D., Tomlinson, James S.

Get full text

Correlation of 68Ga-FAPi-46 PET Biodistribution with FAP Expression by Immunohistochemistry in Patients with Solid Cancers: Interim Analysis of a Prospective Translational Exploratory Study by Mona, Christine E, Benz, Matthias R, Hikmat, Firas, Grogan, Tristan R, Lueckerath, Katharina, Razmaria, Aria, Riahi, Rana, Slavik, Roger, Girgis, Mark D, Carlucci, Giuseppe, Kelly, Kimberly A, French, Samuel W, Czernin, Johannes, Dawson, David W, Calais, Jeremie

“…Fibroblast activation protein (FAP)–expressing cancer-associated fibroblasts confer treatment resistance and promote metastasis and immunosuppression. Because…”
Get full text

Lymphadenectomy in Proximal Gastric Cancer-Location, Location, Location by Ye, Linda, Girgis, Mark D, Hines, O Joe

Get more information

Oncologic Outcomes After Robotic Pancreatic Resections Are Not Inferior to Open Surgery by Girgis, Mark D., Zenati, Mazen S., King, Jonathan C., Hamad, Ahmad, Zureikat, Amer H., Zeh, Herbert J., Hogg, Melissa E.

“…OBJECTIVE:Compare oncologic outcomes after open and robotic pancreatic resections for pancreatic adenocarcinoma (PDAC). SUMMARY OF BACKGROUND DATA:Receipt of…”
Get full text

Surgical resection of high‐grade nonfunctional pancreatic neuroendocrine carcinoma is associated with improved survival by Jiang, Jerry, Park, Joon, Kim, Stephanie, Daan, Amanda, Donahue, Timothy, Girgis, Mark D.

“…Background and objectives The role of surgery in the treatment of nonfunctional pancreatic neuroendocrine carcinomas (PNEC) is not well defined. This study…”
Get full text

Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumors Have Similar Disease-Specific Survival Outcome by Mirzaie, Sarah, Park, Joon Y., Mederos, Michael A., Girgis, Mark D.

“…Background Duodenal neuroendocrine tumors (dNETs) are rare, and their management is not well-defined. National Comprehensive Cancer Network (NCCN) guidelines…”
Get full text

A Review of Acute Pancreatitis—Reply by Girgis, Mark D, Mederos, Michael A, Reber, Howard A

Get full text

Endoscopic therapies for patients with obesity: a systematic review and meta-analysis by Weitzner, Zachary N., Phan, Jennifer, Begashaw, Meron M., Mak, Selene S., Booth, Marika S., Shekelle, Paul G., Maggard-Gibbons, Melinda, Girgis, Mark D.

“…Background Obesity is a major threat to public health and traditional bariatric surgery continues to have low utilization. Endoscopic treatments for obesity…”
Get full text

Carcinoembryonic Antigen for Diagnosis of Colorectal Cancer Recurrence by Kim, Stephanie S, Donahue, Timothy R, Girgis, Mark D

“…Kim et al present a case study of a 78-year-old man with no significant medical or family history of cancer presented with 2 weeks of worsening abdominal pain…”
Get full text

Hispanic/Latino Ethnicity is an Independent Predictor of Worse Survival for Gastric Cancer in a Multicenter Safety-Net Patient Population by Klingbeil, Kyle D, Dillon, Dustin L, Zarrinkhoo, Erfan, Bechay, Kirollos, Park, Joon Y, Rook, Jordan M, Mederos, Michael A, Girgis, Mark D, Chen, Keren, Chen, Kuan-Ting, Bastani, Roshan, Manouchehr-Pour, Shawdi, Dubé, Priyanka, Viragh, Karoly, Thomas, Mariam, Chiu, Victor, Kadera, Brian E

“…Various population-based studies have shown Hispanic/Latino ethnicity is a risk factor for worse survival in patients with gastric cancer linked to disparate…”
Get full text